Absolutely agree, it looks to me like the CML board and senior managers are acting in their own best interest not the shareholders.Just a personal opnion of course. Bring it on I say.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025